(Q39314422)

10 September 2017

title

Synergistic interaction of gabapentin with tiagabine in the formalin test in mice: an isobolographic analysis (English)

1 reference

10 September 2017

0 references

1

Jarogniew J Luszczki

1 reference

10 September 2017

Stanisław Jerzy Czuczwar

series ordinal

5

object named as

Stanislaw J Czuczwar

1 reference

10 September 2017

3

Miroslaw Czuczwar

1 reference

10 September 2017

4

Krzysztof Przesmycki

1 reference

10 September 2017

Agnieszka Kolacz

2

1 reference

10 September 2017

language of work or name

1 reference

16 September 2008

1 reference

10 September 2017

published in

European Journal of Pain

1 reference

10 September 2017

volume

13

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

665-672

1 reference

The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Isobolographic analysis for combinations of a full and partial agonist: curved isoboles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Multimodal analgesia for postoperative pain control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Tiagabine may reduce bruxism and associated temporomandibular joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Basic mechanisms of gabitril (tiagabine) and future potential developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Reflex sympathetic dystrophy treated with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Treatment of painful sensory neuropathy with tiagabine: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

An overview of drug combination analysis with isobolograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Interactions between drugs and occupied receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

The formalin test: an evaluation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Tiagabine and gabapentin for the management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

GABAB receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Spinal Gabapentin and Antinociception: Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

Ethical guidelines for investigations of experimental pain in conscious animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2008.08.002

10.1016/J.EJPAIN.2008.08.002

21 January 2018

Identifiers

DOI

1 reference

release_5zxqord7wjeahjlrmccdztyazm

10 September 2017

Fatcat ID

0 references

1 reference